The Department of Health and Human Services (HHS) recently published the long-awaited new rules related to the Anti-Kickback Statute, Civil Monetary Penalties Law, and the Stark Law (collectively, the “Final Rules”). The Final Rules are part of... Read More
On September 30, 2020, the Department of Justice (“DOJ”) announced a nationwide healthcare fraud and opioid takedown resulting in charges against more than 100 physicians for over $4.5 billion in losses connected to allegedly fraudulent... Read More
The U.S. Attorney’s Office, Western District of Louisiana, recently announced that the owner and operator of the Monroe-based Specialty Drug Testing, LLC (“Specialty”) was indicted by a Federal grand jury for violating the Federal... Read More
In response to the COVIDI9 crisis, the Secretary of the Department of Health and Human Services invoked his authority to issue blanket waivers of Section 1877(g) of the Social Security Act (also known as the physician self-referral law or... Read More
The COVID-19 pandemic has had a profound – and oftentimes chilling – effect on industries and agencies across the board. Law enforcement has likewise been affected. Specifically, social distancing mandates, coupled with staffing deductions and... Read More
Two non-profit corporations organized for the purpose of establishing and administering patient assistance programs have agreed to pay $2 million and $4 million respectively to settle allegations of assisting pharmaceutical manufacturers to pay... Read More
Value Based Care is the future of the United States healthcare system and the Office of the Inspector General (OIG) for the US Department of Health and Human Services is in full agreement. The OIG recently issued a Notice of Proposed Rulemaking that... Read More
On October 7, 2019, the Supreme Court (SCOTUS) denied certiorari in the matter of Pharmerica Corporation v. U.S. ex rel. Silver, leaving on the books the Third Circuit decision which held that the False Claims Act's (FCA) public disclosure bar "is... Read More
Federal prosecutors in Florida and Louisiana have filed multiple indictments related to a nationwide telemedicine fraud scheme involving genetic testing. The arrangement included at least 35 individuals and has resulted in the submission of more... Read More
On September 4, 2019, the United States Department of Justice (DOJ) announced that drug maker Mallinckrodt agreed to pay $15.4 million to resolve claims that its predecessor Questcor Pharmaceuticals paid illegal kickbacks to doctors to induce... Read More
